Showing results (51-60 of 326) with videos related to
Sort By:
Pageof 33
Expert Opinion on Drug Metabolism & Toxicology|January 17, 2013
Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerabilityLeslie CitromeCNS Spectrums|March 2, 2013
Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophreniaLeslie CitromeInternational Journal of Clinical Practice|May 13, 2017
Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Leslie CitromePatient Preference and Adherence|August 27, 2016
Schizophrenia relapse, patient considerations, and potential role of lurasidoneLeslie CitromeExpert Opinion on Pharmacotherapy|November 1, 2011
Olanzapine-fluoxetine combination for the treatment of bipolar depressionLeslie CitromeClinical Schizophrenia & Related Psychoses|July 11, 2012
Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?Leslie CitromeJournal of Affective Disorders|March 4, 2016
Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmedLeslie CitromeExpert Opinion on Drug Metabolism & Toxicology|May 29, 2012
Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerabilityLeslie CitromeExpert Opinion on Drug Metabolism & Toxicology|May 6, 2014
Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolismLeslie CitromePageof 33